<DOC>
	<DOCNO>NCT00813735</DOCNO>
	<brief_summary>Research establish incidence insomnia increase age possible cause contribute sleep problem elderly still explore debate . Older adult use disproportionately large share sleep aid non-prescription sleep aid use increase past decade . This study double blind safety effectiveness trial examine response eszopiclone co-administered escitalopram treatment insomnia symptom geriatric depressed adult insomnia symptom .</brief_summary>
	<brief_title>Eszopiclone Co-Administered With Escitalopram Insomnia Elderly Adults With Major Depressive Disorder</brief_title>
	<detailed_description>This double-blind , randomize , placebo-controlled , parallel-group study . There two group subject Major Depressive Disorder insomnia symptom randomize treatment either eszopicone 2mg placebo daily bedtime 14 week begin visit 2 . Also , subject receive open label treatment escitalopram 10 20mg daily morning . Safety efficacy evaluate well rating scale patient sleep diary .</detailed_description>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>Diagnosis MDD , HAMD score 20 great screen baseline , total sleep time le 6 hour screen baseline , ISI 15 great screen baseline May use psychoactive drugs/psychotropics study , may type dementia , may significant/unstable medical problem , nightshift work permit , current seizure disorders/head injury</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Insomnia</keyword>
	<keyword>Major Depression</keyword>
	<keyword>Geriatric</keyword>
</DOC>